drugset / Trial / NCT00156182
A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study was designed to determine the long-term safety of asoprisnil 10 mg in women with one or more uterine fibroids after an initial 12 weeks in study M99-144.
Timeline
- Start
- 2001-04
- Primary completion
- 2001-12
- Completion
- 2001-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asoprisnil | Other / unclassified | 10 mg | Oral |